However, BADX is generally considered a salvage therapy for CD, since it results in permanent adrenal insufficiency requiring lifelong steroid replacement therapy and carrying the risk of life-threatening adrenal crisis; additionally, there is a continuous risk of ACTH-secreting tumor regrowth due to the loss of negative feedback from cortisol. This evidence concerns the gene POMC and neoplasm.